Double-mode imaging and medicine-loading integrated nano medicine carrier and preparation method thereof
A nano-drug carrier and dual-mode imaging technology, which is applied to medical preparations of non-active ingredients, drug combinations, drug delivery, etc., to achieve the effects of reducing toxic side effects and damage to normal tissues, simple process, and high accuracy
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0030] Example 1: Dissolve doxorubicin hydrochloride in water, add a small amount of triethylamine to extract doxorubicin into dichloromethane. Then carboxy-terminated poly(lactic-co-glycolic acid) (hereinafter referred to as PLGA, Mw=10000, LA:GA=75:25) and upconversion luminescent nanocrystals NaGdF4:Yb, Er were dissolved in dichloromethane. Take a certain amount of each of the three solutions and make 1ml of dichloromethane solution, in which 8mg of PLGA, 4mg of NaGdF4:Yb, Er and 500μg of doxorubicin are dissolved, and this dichloromethane solution is added dropwise to 10ml containing 1 In the aqueous solution of % PVA, stir at 16000rpm for 10min to form a stable O / W emulsion, then gently stir in a water bath at 40°C for 6h to volatilize dichloromethane and solidify the nanospheres. The nanospheres in the suspension are collected by centrifugation, washed several times with double distilled water, and freeze-dried to obtain the functional nanometer drug carrier.
Embodiment 2
[0031] Example 2: Paclitaxel, carboxy-terminal PLGA (Mw=10000, LA:GA=75:25) and upconversion luminescent nanocrystals NaGdF4:Yb, Er were dissolved in dichloromethane, respectively. Take a certain amount of each of the three solutions to make 1ml of dichloromethane solution, so that 8mg of PLGA, 4mg of NaGdF4:Yb, Er and 500μg paclitaxel are dissolved in it, and inject the dichloromethane solution into 10ml of 1% PVA-containing aqueous solution , stirred at 16000rpm for 10min to form a stable O / W emulsion, then gently stirred in a water bath at 40°C for 6h to volatilize dichloromethane and solidify the nanospheres. The nanospheres in the suspension are collected by centrifugation, washed several times with double distilled water, and freeze-dried to obtain the functional nanometer drug carrier.
Embodiment 3
[0032] Example 3: Paclitaxel, carboxy-terminal PLGA (Mw=10000, LA:GA=75:25) and upconversion luminescent nanocrystals NaGdF4:Yb, Er were dissolved in dichloromethane, respectively. A certain amount of each of the three solutions was prepared into 1 ml of dichloromethane solution, in which 8 mg of PLGA, 4 mg of NaGdF4:Yb, Er and 500 μg of paclitaxel were dissolved. Weigh 56mg of SDS and dissolve it in 10ml of deionized water, then inject this 1ml of dichloromethane solution into the SDS aqueous solution, stir at 16000rpm for 10min to form a stable O / W emulsion, then gently stir overnight to volatilize the dichloromethane and solidify nanospheres. The nanospheres in the suspension were collected by centrifugation, washed several times with double distilled water, and freeze-dried to obtain functional composite PLGA nanospheres.
PUM
Property | Measurement | Unit |
---|---|---|
Size | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap